Market News AIOpen the app

CMPX stock news · Compass Therapeutics Inc.

Stories about Compass Therapeutics Inc. (CMPX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CMPX

Follow Compass Therapeutics Inc. (CMPX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CMPX
Free on the App Store and Google Play, or on the web.
  1. Sep 23, 2026, 9:23 AM ET · Opinion

    An Autoliv analyst changed their mind and listed the five biggest downgrades for Wednesday.

    Bad for CMPX

    Wedbush cut Compass Therapeutics from Outperform to Neutral and cut the price target from $5 to $1, a large reduction in expectations. That steep cut signals much weaker analyst views and hurts sentiment.

  2. Sep 22, 2026, 1:33 PM ET · Market

    On Tuesday, 12 health care stocks changed a lot, with Jaguar Health jumping 304.5% and Silexion Therapeutics dropping 3%.

    Neutral

    The article reports Compass Therapeutics shares fell 26.65% intraday. It provides no business details, so it does not change how we read Compass Therapeutics.

  3. Sep 22, 2026, 8:38 AM ET · Trial

    Compass Therapeutics shares news from the FDA about its cancer treatment.

    Neutral

    Compass filed an 8-K about FDA feedback on tovecimig but gave no feedback details, so it does not change how we read Compass today.